SUPPLEMENTARY MATERIAL 1: FIGURE S1: Spectrophotometry results of crystal violet staining demonstrating the effects of PPV (10–300 M) on proliferation on MDA-MB-231 cells compared to A549- and DU145 cell lines at 24 h, FIGURE S2: Spectrophotometry results of crystal violet staining demonstrating the effects of PPV (10–300 M) on proliferation on MDA-MB-231 cells compared to A549- and DU145 cell lines at 96 h.
SUPPLEMENTARY MATERIAL 2: FIGURE S1: Light microscopy images of cell morphology demonstrating the effects of PPV ((10–150 M) on cell morphology on MDA-MB-231 cells at 48 h at a magnification of 10. TABLE S1: table displaying the effects of papaverine on morphology as percentage change when compared to cells propagated in growth medium on MDA-MB-231 at 48 h. FIGURE S2: Light microscopy images of cell morphology demonstrating the effects of PPV ((10–150 M) on cell morphology on A549 cells at 48 h at a magnification of 10. TABLE S2: table displaying the effects of papaverine on morphology as percentage change when compared to cells propagated in growth medium on A549 at 48 h. FIGURE S3: Light microscopy images of cell morphology demonstrating the effects of PPV ((10–150 M) on cell morphology on DU145 cells at 48 h at a magnification of 10 TABLE S3: table displaying the effects of papaverine on morphology as percentage change when compared to cells propagated in growth medium on DU145 at 48 h. FIGURE S4: Light microscopy images of cell morphology demonstrating the effects of PPV ((10–150 M) on cell morphology on MDA-MB-231 cells at 72 h at a magnification of x10. TABLE S4: table displaying the effects of papaverine on morphology as percentage change when compared to cells propagated in growth medium on MDA-MB-231 at 72 h. FIGURE S5: Light microscopy images of cell morphology demonstrating the effects of PPV ((10–150 M) on cell morphology on A549 cells at 72 h at a magnification of 10. TABLE S5: table displaying the effects of papaverine on morphology as percentage change when compared to cells propagated in growth medium on A549 at 72 h. FIGURE S6: Light microscopy images of cell morphology demonstrating the effects of PPV ((10–150 M) on cell morphology on DU145 cells at 72 h at a magnification of 10. TABLE S6: table displaying the effects of papaverine on morphology as percentage change when compared to cells propagated in growth medium on DU145 at 72 h. FIGURE S7. Light microscopy results demonstrating the effects of ESE-ol used as a positive control on cell morphology.
SUPPLEMENTARY MATERIAL 3; TABLE S1. table displaying the effects of papaverine on oxidative stress as a change of fluorescence intensity relative to the fluorescence intensity of cells propagated in growth medium on MDA-MB-231-, A549- and DU145 cell lines at 48 h. FIGURE S1. Fluorescence staining showing H2O2 production in MDA-MB-231 cells after 48 h. FIGURE S2. Fluorescence staining showing H2O2 production in A549 cells after 48 h. FIGURE S3. Fluorescence staining showing H2O2 production in MDA-MB-231 cells after 48 h. TABLE S2. table displaying the effects of papaverine on oxidative stress as a change of fluorescence intensity relative to the fluorescence intensity of cells propagated in growth medium on MDA-MB-231-, A549- and DU145 cell lines at 72 h. FIGURE S4. Fluorescence staining showing H2O2 production in MDA-MB-231 cells after 72 h. FIGURE S5. Fluorescence staining showing H2O2 production in A549 cells after 72 h. FIGURE S6. Fluorescence staining showing H2O2 production in MDA-MB-231 cells after 72 h.
SUPPLEMENTARY MATERIAL 4: FIGURE S1. Flow cytometry results demonstrating the effects of PPV (10–150 M) on the cell cycle on MDA-MB-231-, A549- and DU145 cells at 48 h. FIGURE S2. Cell cycle progression of MDA-MB-231 cells treated with PPV (10–150 M) at 48 h. FIGURE S3. Cell cycle progression of A549 cells treated with PPV (10–150 M) at 48 h. FIGURE S4. Cell cycle progression of DU145 cells treated with PPV (10–150 M) at 48 h. FIGURE S5. Flow cytometry results demonstrating the effects of PPV (10–150 M) on the cell cycle on MDA-MB-231-, A549- and DU145 cells at 72 h. FIGURE S6. Cell cycle progression of MDA-MB-231 cells treated with PPV (10–150 M) at 72 h. FIGURE S7. Cell cycle progression of A549 cells treated with PPV (10–150 M) at 72 h. FIGURE S8. Cell cycle progression of DU145 cells treated with PPV (10–150 M) at 72 h.